IMMA is one of the winners of this year MassChallenge Israel competition. IMMA is a women-led new Israeli venture, created by Dr. Beatrice Chemla and Dr. Nadia Prisant, two graduates of our MBA in Healthcare Innovation, led by Prof. Varda Liberman
Arison school of business is proud to announce that IMMA is one of the winners of this year MassChallenge Israel competition.
IMMA is a women-led new Israeli venture, created by Dr. Beatrice Chemla and Dr. Nadia Prisant, two graduates of our Healthcare Innovation MBA program, led by Prof. Varda Liberman. They came with the idea during the course “planning & financing new ventures” by Dr. Amir Gutman and the follow-on course “Managing an enterprise in a changing environment” by Dr. Yossi Bolles. The team won their first tlv bootcamp in September 2020. Shortly after completing the program, they have launched IMMA with Beatrice as CEO and Nadia as CMO, enrolling two other graduates in their Advisory Board, Dr. Muriel Webb and Shlomi Gilad.
 |
Dr. Beatrice Chemla |
 |
Dr. Nadia Prisant |
IMMA is developing a comprehensive solution aimed at the rapidly-expanding women’s fertility market. IMMA is an at-home ovarian stimulation monitoring system that enables women to perform their own follicle stimulation follow-ups by themselves, for themselves, in the intimacy and comfort of their home. in an easy-to-scan, easy-to-check solution.
IMMA will be part of the MassChallenge US Roadshow in NY and Boston in early October 2021.
